Drug Pipeline

Lebrikizumab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
11
Active Studies
3
Recruiting
7
Phase 3
4
Top Sponsors
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-23 NCT07006792
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic…
overall status: "Recruiting" → "Active Not Recruiting"
2026-05-23 NCT07006792
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic…
Enrollment increased: 200 -> 233 participants
2026-05-23 NCT07006792
A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic…
date change Primary completion pushed: 2026-04 -> 2026-05-14
2026-05-16 NCT07471932
A Study of LAD106 in Healthy Adult Participants
date change Primary completion pushed: 2026-06-30 -> 2027-05-31
2026-05-16 NCT07471932
A Study of LAD106 in Healthy Adult Participants
date change Completion pushed: 2026-06-30 -> 2027-05-31
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-06-02 NCT07620561 Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 4
2
Phase 3
7
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07006792 A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic… Atopic Dermatitis Active, Not Recruiting
NCT07352566 Utilization of a Microdevice for Psoriasis and Atopic Dermatitis Psoriasis Not Yet Recruiting
Phase 3
NCT06339008 A Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis… Perennial Allergic Rhinitis (PAR) Recruiting
NCT06338995 A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal… Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Recruiting
NCT05559359 A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With… Atopic Dermatitis Active, Not Recruiting
NCT06921759 A Study to Investigate the Efficacy and Safety of Lebrikizumab in Participants With… Atopic Hand and Foot Dermatitis Active, Not Recruiting
NCT06526182 A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe… Dermatitis, Atopic Active, Not Recruiting
NCT05735483 A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in… Atopic Dermatitis Enrolling by Invitation
NCT07542483 A Study of Lebrikizumab in Adults With Nummular Eczema Nummular Eczema Not Yet Recruiting
Phase 2
NCT07620561 Efficacy and Speed of Response of Lebrikizumab in High-Burden Prurigo Nodularis Patients Prurigo Nodularis (PN) Not Yet Recruiting
Phase 1
NCT07471932 A Study of LAD106 in Healthy Adult Participants Healthy Volunteers Recruiting
Sponsors Running Lebrikizumab Trials
Disease Areas
Get alerts when Lebrikizumab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free